TuHURA Biosciences Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
TuHURA Biosciences Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
HURA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001498382

Board of directors

Follow this board

Chief executives

James A. Bianco · Chief Executive Officer
Since October 2024
Robert E. Hoffman · President, CEO, and CFO
Until October 2024 · Former

Board connections

4 of this board's directors also sit on 6 other boards.

Network of TuHURA Biosciences Inc.'s board connections Artelo Biosciences Inc. Artelo Biosciences Inc... Calidi Biotherapeutics Inc. Calidi Biotherapeutics... FibroBiologics Inc. FibroBiologics Inc. Opus Genetics Inc. Opus Genetics Inc. Processa Pharmaceuticals Inc. Processa Pharmaceutica... Zevra Therapeutics Inc. Zevra Therapeutics Inc... George K. Ng George K. Ng James S. J. Manuso James S. J. Manuso Robert E. Hoffman Robert E. Hoffman Tamara A. Seymour Tamara A. Seymour TuHURA Biosciences Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 18, 2024 James A. Bianco Director, Officer (Chief Executive Officer) Grant or award +2,323,307 — —
Jun 1, 2023 Robert E. Hoffman Director, Officer (President, CEO, and CFO) Grant or award +59,800 — —
Jan 5, 2023 Brown Dennis M Officer (Chief Scientific Officer) Inheritance +363 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.